Nervous System Software is not as reliable as it used to be, a new study has found.
Researchers from the University of Cambridge’s Department of Neurology and Neuroscience said that despite the use of newer, more reliable software, the nervous system still remains vulnerable to drug-induced damage.
The researchers said the software, called ‘Nest’, had improved its stability, but had not improved its safety.
Nest is an artificial intelligence (AI) program that learns to recognise certain drugs and other things that might damage the nervous systems.
It uses a neural network to understand what drugs can do to a nervous system.
In addition, the researchers said Nest also uses ‘supervised learning’ to recognise the types of drugs and drugs behaviours that can lead to an increase in the rate of nerve damage.
‘Nest’ is a free program which can be downloaded from the Google Play Store.
What is the nervous process?
The nervous system consists of neurons that are responsible for coordinating movement and balance.
The neural network learns to identify drugs that can damage the central nervous system and the central autonomic nervous system (CNS).
When the neural network detects that a drug is present, it releases a chemical called endorphins.
These chemicals act like an ‘anesthetic’, and if the drug is ingested, the central and peripheral nervous systems can be damaged.
How can you prevent damage?
The researchers have already used Nest to detect the drugs that could cause damage to the nervous and central nervous systems, but the next step is to test the safety of the software on human subjects.
To do so, they plan to ask participants to complete tasks that simulate how they might feel in a clinical setting, like driving a car.
Participants will then be tested in a lab environment, and then have the software analyse their reactions to the drugs and how the drugs caused the damage.
They will then record their responses to the same drug and to different drugs to determine if they are safe or not.’
We hope to use this to inform clinical trial research on drug safety,’ the researchers wrote.
Dr Chris Smith, one of the study’s authors, said: ‘The next step for us is to develop a more robust and more effective system that can be used to diagnose, and treat, drugs and their interactions with the nervous tissue.’
The results are published in the journal Science Translational Medicine.
More on the nervous processes from the BBC: